	Prevalence and spectrum of variants in homologous recombination repair genes in ovarian cancer in Latin America: a systematic review and meta-analysis. AJOG Glob Rep Vargas-Castellanos E, Santiago-Tovar N, Murcia-Soriano L, Patino-Herrera A, Parra-Medina R, Riano-Moreno JC. PMID: 42898852 [PubMed]
	Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential. Front Microbiol Li Y, Zhou L, Huang R, Wang Y, Zhao H, Sun M, Zhang Y, Wu Z, Li J. PMID: 42898827 [PubMed]
	The blood-brain tumor barrier as a spatial immune checkpoint in glioblastoma: leukocyte entry, perivascular retention, and therapeutic implications. Front Immunol Lin F. PMID: 42898795 [PubMed - indexed for MEDLINE]
	Beyond combination: sequencing priming modalities before immune checkpoint inhibitors to convert immunologically cold tumors toward an ICI-responsive phenotype. Front Immunol Fan W, Xu H, Wu Y, Peng Y. PMID: 42898787 [PubMed - indexed for MEDLINE]
	Integrative options for the management of anxiety and depression in people with cancer. Front Oncol Carlson LE, Deleemans JM, Savard C, Marshall N, Irving ET, Petersson JN, Conradi HSW, Mallya S. PMID: 42898778 [PubMed]
	Advancing Early Breast Cancer Diagnosis and Ki-67 Expression Prediction With Ultrasound Viscoelastography: Based on Peritumoral Assessment. Health Sci Rep Huang X, Zhang B, Chen F, Wei C, Lan B, Yang H, Deng D, Zou Q. PMID: 42898743 [PubMed]
	Intratumoral microbiota and their emerging role in the tumor microenvironment. Microbiome Res Rep Hui X, Ding S, Gao G, Gao S, Tian J, Xu S, Yan B, Zhang R, Zhao T, Wang H. PMID: 42898724 [PubMed]
	The Current Status and Evaluation of Artificial Intelligence in Bladder Cancer: Clinical Applications and Research. Comput Struct Biotechnol J Yin Z, Ho JWK. PMID: 42898717 [PubMed]
	ER(-)/PR(+) breast cancer: from diagnostic discordance to precision therapy. Front Oncol Shao Y, Zhou M, Hu Z, Wu B, Zhou J. PMID: 42898714 [PubMed]
	CAPTYN, a Blood-Based Machine-Learning Model Predicting Clinical Benefit of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: Validation in the IMbrave150 Trial. Cancer Commun (Lond) Jo GH, Hwang S, Scheiner B, Woo S, Lee WS, Kang B, Kim JS, Lim HY, An C, Kim DY, Kim I, Heo DH, Pinter M, Kim BK, Kim C, Chon HJ. PMID: 42898707 [PubMed - in process]
	Return to Work After Adjuvant Chemotherapy for Colon Cancer: A Retrospective Study With Exploratory Occupational Analysis. Cureus Duarte Branco V, Liz F, Orey M, Frazão P, Abreu M, Malheiro M, Santos Amador S, Cardoso D, Martins A. PMID: 42898704 [PubMed]
	Multimodal biomarkers for early detection and immunotherapy assessment in hepatocellular carcinoma: integrating liquid biopsy, AI-based imaging and tumor immune profiling. Front Genet Zhao Y, Chen X, Zhao H. PMID: 42898703 [PubMed]
	Redefining drug discovery: AI-driven strategies for efficient cancer therapeutics. Front Oncol De D, Chakraborty S, Banerjee S. PMID: 42898694 [PubMed]
	Paraptosis, a new type of cell death that can be applied to cancer treatment. Front Oncol Wang X, Ma J, Tan B, Wang Y, Wang Z, Hou C, Chen Q, Jin X. PMID: 42898690 [PubMed]
	Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous Cell Carcinoma: From Normal Epithelium to Precancerous Lesions and Carcinoma. Cancer Commun (Lond) Lan L, Wang X, Jiang X, Lin X, Lai Y, Tan W, Zhang S, Lin D, Wu C. PMID: 42898679 [PubMed - indexed for MEDLINE]
	Marijuana (Cannabis) Smoking Increases the Risk of Lung Cancer: Evidence from a Systematic Review and Meta-Analysis. Addict Health Karimi M, Kazemi K, Pourhanifeh MH, Irajian P, Asbaghi O. PMID: 42898671 [PubMed]
	From density to spatial function: spatial multi-omics, composite biomarker design, and therapeutic engineering of tertiary lymphoid structures in solid tumors. Front Immunol Wang X, Lin L. PMID: 42898662 [PubMed - indexed for MEDLINE]
	Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers. Front Immunol Zeng L, Wei S, Chen N, Xie X. PMID: 42898640 [PubMed - indexed for MEDLINE]
	The role of microbiota on thyroid cancer: from carcinogenicity, treatment and predictability. Front Immunol Han JL, Lu XD, Du JJ. PMID: 42898634 [PubMed - indexed for MEDLINE]
	Efficacy of immune-oncology combinations versus sunitinib in patients with bone metastases from renal cell carcinoma: A systematic review and meta-analysis of phase III trials with long-term follow-up. J Bone Oncol de Albuquerque CFA, Reis LCS, Manna EDF, Zafalon AES, Yabrude ATZ, Porta C. PMID: 42898627 [PubMed]

Articles 1 - 20 / 1982296

Page 1 of 99115



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy